Global Alzheimer’s Initiative Now Act

Advancement of Medical Care: The bill aims to advance international efforts to prevent, diagnose, and treat Alzheimer's disease and dementia (Section 4(a)). This includes developing diagnostics and treatments for diverse populations both in the United States and globally (Section 3(2)(A)).

Benefits to Minority Populations: International Alzheimer's research across all races and ethnicities is noted to directly benefit minority populations in the United States (Section 2(9)).

Economic and Health System Stability: The bill addresses the challenge of aging populations which can impact health and social safety systems (Section 2(3)). By leading global cooperative efforts, the policy aims to promote international development cooperation (Section 3(2)(B)).

Investment Efficiency: The policy aims to provide substantial leverage and burden sharing for United States investments (Section 3(2)(C)).

Financial Requirements: The bill authorizes the use of funds from the Foreign Assistance Act of 1961 to provide United States contributions to the DAC (Section 4(c)(1)).

Funding Constraints: United States contributions can only be used if the DAC secures funding from sources other than the United States, and total U.S. contributions cannot exceed 33 percent of the total funds contributed to the DAC (Section 4(c)(2)).